Pfizer (PFE) prepares to report its first-quarter earnings on April 29, and analysts have adopted a cautious stance on the pharmaceutical giant’s stock. Analysts’ expectations have been tempered by ...

The California Newsroom and the Texas Standard team up to examine how the Trump administration is changing life in two of the ...

The summer season is upon us and, per each year, we’ve dug beyond studio offerings to present an in-depth look at what should ...